{{Drugbox
| IUPAC_name = (3''R'')-6-Chloro-3-methyl-5,10-dihydroimidazo[2,1-b]quinazolin-2(3''H'')-one
| image = Quazinone.svg

<!--Clinical data-->
| tradename =
| pregnancy_category =
| legal_status = Rx-only
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =
| metabolism =
| elimination_half-life =
| excretion =

<!--Identifiers-->
| CAS_number = 70018-51-8
| ATC_prefix = None
| ATC_suffix =
| PubChem = 6603980
| ChemSpiderID = 5036286
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = D1Q7F6C2FP
| KEGG = D05668
| synonyms = Ro 13-6438

<!--Chemical data-->
| C=11 | H=10 | Cl=1 | N=3 | O=1 
| molecular_weight = 235.67 g/mol
| smiles = Clc1cccc3c1CN2/C(=N\C(=O)[C@H]2C)N3
}}

'''Quazinone''' ('''Dozonone''') is a [[cardiotonic]] and [[vasodilator]] [[drug]] which was developed and marketed in the 1980s for the treatment of [[heart disease]].<ref name="isbn0-412-46630-9">{{cite book | author = David J. Triggle | title = Dictionary of Pharmacological Agents | publisher = Chapman & Hall/CRC | location = Boca Raton | year = 1996 | pages = | isbn = 0-412-46630-9 | oclc = | doi = | url = https://books.google.com/books?id=A0THacd46ZsC&lpg=PA1716&dq=Quazinone&as_brr=3&pg=PA1716#v=onepage&q&f=false}}</ref><ref name="pmid6202980">{{cite journal |vauthors=Eigenmann R, Gerold M, Holck M | title = Cardiovascular profile of Ro 13-6438, a novel positive inotropic agent with vasodilating properties | journal = Journal of Cardiovascular Pharmacology | volume = 6 | issue = 3 | pages = 511–9 | year = 1984 | pmid = 6202980 | doi = 10.1097/00005344-198405000-00021| url = }}</ref><ref name="pmid6202981">{{cite journal |vauthors=Holck M, Thorens S, Muggli R, Eigenmann R | title = Studies on the mechanism of positive inotropic activity of Ro 13-6438, a structurally novel cardiotonic agent with vasodilating properties | journal = Journal of Cardiovascular Pharmacology | volume = 6 | issue = 3 | pages = 520–30 | year = 1984 | pmid = 6202981 | doi = 10.1097/00005344-198405000-00022| url = }}</ref><ref name="pmid2580156">{{cite journal |vauthors=Belz GG, Stern HC, Butzer R | title = Dose-response following single administrations of a new cardiac performance enhancer RO 13-6438 in normal volunteers | journal = Journal of Cardiovascular Pharmacology | volume = 7 | issue = 1 | pages = 86–90 | year = 1985 | pmid = 2580156 | doi = 10.1097/00005344-198501000-00014| url = }}</ref><ref name="pmid4003296">{{cite journal  |vauthors=Daly PA, Chatterjee K, Viquerat CE, etal | title = RO13-6438, a new inotrope-vasodilator: systemic and coronary hemodynamic effects in congestive heart failure | journal = The American Journal of Cardiology | volume = 55 | issue = 13 Pt 1 | pages = 1539–44 |date=June 1985 | pmid = 4003296 | doi = 10.1016/0002-9149(85)90969-5| url = }}</ref> It acts as a [[binding selectivity|selective]] [[PDE3]] [[PDE3 inhibitor|inhibitor]].<ref name="pmid10856433">{{cite journal |vauthors=Osinski MT, Schrör K | title = Inhibition of platelet-derived growth factor-induced mitogenesis by phosphodiesterase 3 inhibitors: role of protein kinase A in vascular smooth muscle cell mitogenesis | journal = Biochemical Pharmacology | volume = 60 | issue = 3 | pages = 381–7 |date=August 2000 | pmid = 10856433 | doi = 10.1016/S0006-2952(00)00328-2| url = http://linkinghub.elsevier.com/retrieve/pii/S0006-2952(00)00328-2}}</ref><ref name="pmid10079010">{{cite journal |vauthors=Denis D, Riendeau D | title = Phosphodiesterase 4-dependent regulation of cyclic AMP levels and leukotriene B4 biosynthesis in human polymorphonuclear leukocytes | journal = European Journal of Pharmacology | volume = 367 | issue = 2-3 | pages = 343–50 |date=February 1999 | pmid = 10079010 | doi = 10.1016/S0014-2999(98)00987-X| url = }}</ref> It is no longer available.<ref name="isbn0-412-46630-9"/>

== See also ==
* [[Phosphodiesterase inhibitor]]

== References ==
{{Reflist}}

{{Phosphodiesterase inhibitors}}
{{Cardiac stimulants excluding cardiac glycosides}}

[[Category:Chloroarenes]]
[[Category:Imidazoquinazolines]]
[[Category:Inotropic agents]]
[[Category:Lactams]]
[[Category:PDE3 inhibitors]]
[[Category:Vasodilators]]